Physician profile
Divyang A Joshi
NPI 1528053568
$1,366.82
in general payments reported to CMS, 2019-2025
16 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $70.49 · 2021: $102 · 2022: $251 · 2023: $285 · 2024: $325 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $275.87 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.50 | 2019-2025 | Jascayd |
| Lilly USA, LLC | $175.22 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $168.76 | 2019-2025 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $103.25 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $92.16 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $72.70 | 2023-2024 | Spravato, Xarelto |
| Glaxosmithkline, LLC. | $60.74 | 2023-2024 | Arexvy, Shingrix |
| Pfizer INC. | $41.80 | 2019-2022 | |
| Edwards Lifesciences Corporation | $39.89 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $37.41 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.42 | 2023 | |
| Amgen INC. | $29.33 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $26.55 | 2022 | |
| Sumitomo Pharma America, INC. | $19.52 | 2023 | Aptiom |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $16.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divyang Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.